Velarion Records
Free. Unsubscribe any time.

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. filed 32 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 57 transactions and 1,070,875 shares. 32 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Axsome Therapeutics, Inc. 57

Adoption dates in Axsome Therapeutics, Inc. 0

Results prints in Axsome Therapeutics, Inc. 9

Trades before a print in Axsome Therapeutics, Inc. 7

Interval to Axsome Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.